We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$372M
AUM Growth
–
Cap. Flow
+$366M
Cap. Flow %
98.47%
Top 10 Hldgs %
42.39%
Holding
134
New
131
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$37.8M
2
GLD icon
SPDR Gold Trust
GLD
+$27.4M
3
JPM icon
JPMorgan Chase
JPM
+$20.4M
4
MET icon
MetLife
MET
+$16.7M
5
XOM icon
ExxonMobil
XOM
+$12.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 28.54%
2 Energy 13.83%
3 Healthcare 9.26%
4 Real Estate 8.89%
5 Technology 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPHD
101
DELISTED
Cepheid Inc
CPHD
$301K 0.08%
+8,750
New +$321K
HTWR
102
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$294K 0.08%
+3,087
New +$281K
MRK icon
103
Merck
MRK
$316B
$292K 0.08%
+6,588
New +$294K
AMGN icon
104
CALL
Amgen
AMGN
$210B
$286K 0.08%
+2,900
New +$301K
CSCO icon
105
Cisco
CSCO
$480B
$281K 0.08%
+11,550
New +$260K
CCEP icon
106
Coca-Cola Europacific Partners
CCEP
$46.9B
$264K 0.07%
+7,500
New +$276K
HSP
107
CALL
DELISTED
HOSPIRA INC
HSP
$264K 0.07%
+6,900
New +$233K
KO icon
108
Coca-Cola
KO
$372B
$252K 0.07%
+6,286
New +$260K
COV
109
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$251K 0.07%
+4,512
New +$261K
SYK icon
110
CALL
Stryker
SYK
$129B
$246K 0.07%
+3,800
New +$252K
AEGR
111
DELISTED
Aegerion Pharmaceuticals
AEGR
$244K 0.07%
+3,860
New +$205K
NBIX icon
112
CALL
Neurocrine Biosciences
NBIX
$16.9B
$240K 0.06%
+17,900
New +$220K
VTRS icon
113
CALL
Viatris
VTRS
$20.6B
$239K 0.06%
+7,700
New +$230K
BDX icon
114
CALL
Becton Dickinson
BDX
$46.9B
$237K 0.06%
+2,460
New +$235K
WCRX
115
CALL
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$235K 0.06%
+11,800
New +$200K
EW icon
116
CALL
Edwards Lifesciences
EW
$51.6B
$229K 0.06%
+20,400
New +$241K
JAZZ icon
117
CALL
Jazz Pharmaceuticals
JAZZ
$16.4B
$227K 0.06%
+3,300
New +$202K
BSX icon
118
CALL
Boston Scientific
BSX
$71.1B
$213K 0.06%
+23,000
New +$195K
CAH icon
119
CALL
Cardinal Health
CAH
$54.7B
$212K 0.06%
+4,500
New +$206K
COR icon
120
CALL
Cencora
COR
$59.6B
$212K 0.06%
+3,800
New +$206K
ZBH icon
121
CALL
Zimmer Biomet
ZBH
$18.5B
$210K 0.06%
+2,884
New +$216K
NKTR icon
122
Nektar Therapeutics
NKTR
$2.46B
$200K 0.05%
+1,153
New +$177K
STI
123
CALL
DELISTED
SunTrust Banks, Inc.
STI
$161K 0.04%
+5,100
New +$155K
ITMN
124
CALL
DELISTED
INTERMUNE INC
ITMN
$101K 0.03%
+10,500
New +$100K
CLDX icon
125
CALL
Celldex Therapeutics
CLDX
$3.07B
$78K 0.02%
+333
New +$65.6K
2 3 4
5
6

Similar funds

SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.76B AUM 26.04% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

ArrowMark Colorado Holdings's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for ArrowMark Colorado Holdings, which disclosed 134 positions worth $372M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Citigroup: 785,556 shares worth $37.7M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, followed by Energy and Healthcare.

  • ArrowMark Colorado Holdings's largest Q2 2013 buy was Citigroup: 785,556 shares worth $37.7M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 42% of its $372M portfolio in Q2 2013.
  • ArrowMark Colorado Holdings disclosed 134 positions in Q2 2013, its first 13F filing on record.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2013, filed 14 Aug 2013.